Search Results

CIQ 5mg 5mg  | Purity Not Available

Adooq Bioscience

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.

More Information Supplier Page

CIQ 25mg 25mg  | Purity Not Available

Adooq Bioscience

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.

More Information Supplier Page

CIQ 10mg 10mg  | Purity Not Available

Adooq Bioscience

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.

More Information Supplier Page

L-701324 50mg 50mg  | Purity Not Available

Adooq Bioscience

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,

More Information Supplier Page

L-701324 25mg 25mg  | Purity Not Available

Adooq Bioscience

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,

More Information Supplier Page

L-701324 10mg 10mg  | Purity Not Available

Adooq Bioscience

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,

More Information Supplier Page

AI-10-49 5mg 5mg  | Purity Not Available

Adooq Bioscience

AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF??-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM,

More Information Supplier Page

PRT-060318 5mg 5mg  | Purity Not Available

Adooq Bioscience

PRT-060318 is a novel selective inhibitor of the tyrosine kinase Syk, as an approach to HIT treatment.

More Information Supplier Page

GW627368 2mg 2mg  | Purity Not Available

Adooq Bioscience

GW627368 is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM).

More Information Supplier Page